▲ BUY
10
/ 10
Conviction
$ Value
$50K
Shares
21,000
Price
$2
Filed
Jun 20
▶ Why this score? (10/10)
- ✓ Open market buy (+3)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ 10%+ owner (+1)
- ✓ Cluster: 3 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Zeskind Benjamin J.
Title
PRESIDENT AND CEO
CIK
0001870062
Roles
Director
Officer
10% Owner
Transaction Details
Transaction Date
2025-06-18
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
2,302,852
Footnotes
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.31 to $2.44. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price. | Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.
Filing Info
Zeskind Benjamin J.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-03 | IMRX | A | $0 |
| 2025-07-02 | IMRX | ▲ | $25K |
| 2025-07-01 | IMRX | ▲ | $10K |
| 2025-06-18 | IMRX | ▲ | $50K ★ |
Other Insiders at IMRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Matushansky Igor
Chief Medical Officer
|
— | — | 2026-02-03 |
|
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
|
— | — | 2026-02-03 |
|
Zeskind Benjamin J.
PRESIDENT AND CEO
|
— | — | 2026-02-03 |
|
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-02-03 |
|
Morales Mallory
SVP Finance, CAO
|
— | — | 2026-02-03 |
|
Neufeld Leah R
CHIEF PEOPLE OFFICER
|
— | — | 2026-03-13 |
|
Brakewood Harold Eugene
Chief Business Officer
|
— | — | 2026-02-03 |